Results 131 to 140 of about 2,176,861 (324)

Plasma Cell Mucositis: A 20‐Year Retrospective Review at a Tertiary Center

open access: yesJEADV Clinical Practice, EarlyView.
ABSTRACT Background Plasma cell mucositis (PCM) is a rare, chronic inflammatory condition of mucosal surfaces that is likely underdiagnosed and underreported, with limited data on its clinical characteristics, extracavitary involvement, and treatment outcomes.
Miguel A. Aristizabal‐Torres   +4 more
wiley   +1 more source

Capturing patient-reported sleep disturbance in atopic dermatitis clinical trials

open access: yesJournal of Patient-Reported Outcomes
Background Patient-focused approaches to capturing day-to-day variability in sleep disturbance are needed to properly evaluate the sleep benefits of new treatments.
Carla Dias-Barbosa   +8 more
doaj   +1 more source

Pruritus in chronic cholestatic liver diseases

open access: yes, 2017
Pruritus can be a prominent symptom  in patients with chronic liver disorders, especially those  with cholestasis,  and  substantially  affects  quality  of life.
E. A. Orlova   +6 more
core   +1 more source

When Treatment Meets Natural History: Understanding Early Dermatitis‐Related Adverse Events in Systemic Atopic Dermatitis Trials

open access: yesJEADV Clinical Practice, EarlyView.
ABSTRACT Biologics and Janus kinase (JAK) inhibitors have transformed the management of atopic dermatitis (AD), yet some patients experience early worsening of disease activity during treatment initiation. In clinical trials, these events are typically recorded as treatment‐emergent adverse events (TEAEs), most commonly coded as “atopic dermatitis”. We
Diego Ruiz Dasilva   +17 more
wiley   +1 more source

A Practical Guide for Incorporating Emollients in the Treatment of Mild‐to‐Moderate Atopic Dermatitis

open access: yesJEADV Clinical Practice, EarlyView.
ABSTRACT Emollients and cleansers are essential components in managing atopic dermatitis (AD). While international evidence‐based guidelines recommend using gentle cleansers and emollients daily as a foundational therapy for AD, implementation in practice remains suboptimal.
Mette Deleuran   +12 more
wiley   +1 more source

Comparison of itch characteristics and sleep in patients with brachioradial pruritus and notalgia paresthetica: A retrospective analysis from 2 itch centers

open access: yesJAAD International, 2021
Zoe M. Lipman, BS   +5 more
doaj   +1 more source

[Development of a German language questionnaire for assessing chronic pruritus (AGP-questionnaire): background and first results].

open access: yes, 2011
Chronic pruritus may manifest itself clinically in terms of different duration, intensity and quality. There is no questionnaire assessing these parameters systematically.
Weisshaar, E;Stander, S;Gieler, U;Matterne, U;Darsow, U
core   +1 more source

Serum Eosinophil Level Correlates With Atopic Dermatitis Severity: A Multicenter Cross‐Sectional Study in Chinese Patients With a Nested Cohort Analysis of Dupilumab Treatment Response

open access: yesJEADV Clinical Practice, EarlyView.
ABSTRACT Background Personalized treatment strategies for atopic dermatitis (AD) are limited. Although serum total IgE (tIgE) and blood eosinophil levels are proposed biomarkers for AD severity, their clinical utility requires validation. Objectives We aimed to identify biomarkers reflecting AD severity and their association with dupilumab efficacy ...
Zhuying Zhang, Jingwen Xue, Yi Zhao
wiley   +1 more source

Home - About - Disclaimer - Privacy